← Leaderboards

Christopher B Newgard

University Of Texas Sw Med Ctr/Dallas

Google Scholar ↗PubMed ↗ORCID ↗

$30,587,994

Attributed

$44,936,867

Total exposure

27

Grants

21

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $6M · FY2005–25

$10M$7.5M$5M$2.5M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$66,995,638 · 28

By mechanism

P01$31,676,213 · 8

U24$15,479,691 · 1

R01$13,882,970 · 4

R37$3,543,401 · 1

P30$1,182,028 · 3

R24$517,189 · 1

Top collaborators

Most similar at University Of Texas Sw Med Ctr/Dallas

Same institution · by research overlap

A. Dean Sherry$21,878,817
Craig R. Malloy$13,817,010
Robert J Alpern$3,997,610
Roger H. Unger$2,522,973
Charles Y.c Pak$11,557,463

Others in their field

Top investigators on “Metabolic”

David M Nathan · Massachusetts Institute Of Technology$157,845,616
Joseph J. Eron · Univ Of North Carolina Chapel Hill$144,157,234
Judith S. Currier · University Of California Los Angeles$141,260,706
John M Lachin · George Washington University$139,991,329
Randall J Bateman · Washington University$124,168,384
Carol Nesel · Westat$116,355,411

Research focus

MetabolicMolecularDiabetes MellitusPathway InteractionsCollaborationsMetabolomicsTechnologyInsulin SecretionGlucoseLaboratoriesResponseNon-Insulin-Dependent Diabetes MellitusCellsIslets Of LangerhansProgramsBaseIsletFundingInsulinGenesObesityRegulationGlucose MetabolismBeta Cell

Grant awards (105)

A biochemical roadmap of exercise signal$1,785,399

U24 · FY2025 · DK

Engineered Glucose Metabolism in Insulin Secreting Cells$627,997

R01 · FY2025 · DK · contact PI

Metabolomics Core$242,250

P30 · FY2025 · DK · contact PI

Engineered Glucose Metabolism in Insulin Secreting Cells$610,956

R01 · FY2024 · DK · contact PI

North Carolina Diabetes Research Center$182,896

P30 · FY2024 · DK · contact PI

A biochemical roadmap of exercise signal$1

U24 · FY2024 · DK

Engineered Glucose Metabolism in Insulin Secreting Cells$645,074

R01 · FY2023 · DK · contact PI

Zone-specific mitochondrial functions in regulation of hepatic metabolism$442,750

R21 · FY2023 · AG · contact PI

North Carolina Diabetes Research Center$185,337

P30 · FY2023 · DK · contact PI

A Biochemical Roadmap of Exercise Signaling$1,651,155

U24 · FY2022 · DK

Mechanisms connecting dysregulated BCAA, glucose & lipid metabolism in the pathogenesis of metabolic disease$651,201

R01 · FY2022 · DK · contact PI

Engineered Glucose Metabolism in Insulin Secreting Cells$637,850

R01 · FY2022 · DK · contact PI

North Carolina Diabetes Research Center$187,913

P30 · FY2022 · DK · contact PI

A Biochemical Roadmap of Exercise Signaling$2,400,207

U24 · FY2021 · DK

A Biochemical Roadmap of Exercise Signaling$1,291,879

U24 · FY2021 · DK

Small molecules for expansion of islet beta-cell mass in diabetes$661,279

R01 · FY2021 · DK

Mechanisms connecting dysregulated BCAA, glucose & lipid metabolism in the pathogenesis of metabolic disease$659,801

R01 · FY2021 · DK · contact PI

North Carolina Diabetes Research Center$190,432

P30 · FY2021 · DK · contact PI

A Biochemical Roadmap of Exercise Signaling$2,777,531

U24 · FY2020 · DK

Small molecules for expansion of islet beta-cell mass in diabetes$670,806

R01 · FY2020 · DK

Mechanisms connecting dysregulated BCAA, glucose & lipid metabolism in the pathogenesis of metabolic disease$666,411

R01 · FY2020 · DK · contact PI

North Carolina Diabetes Research Center$193,200

P30 · FY2020 · DK · contact PI

A Biochemical Roadmap of Exercise Signaling$2,578,253

U24 · FY2019 · DK

A Biochemical Roadmap of Exercise Signaling$1,430,327

U24 · FY2019 · DK

Mechanisms connecting dysregulated BCAA, glucose & lipid metabolism in the pathogenesis of metabolic disease$708,592

R01 · FY2019 · DK · contact PI

Small molecules for expansion of islet beta-cell mass in diabetes$684,336

R01 · FY2019 · DK

Engineered Glucose Metabolism in Insulin Secreting Cells$577,633

R01 · FY2019 · DK · contact PI

A Biochemical Roadmap of Exercise Signaling$1,335,796

U24 · FY2018 · DK

Engineered Glucose Metabolism in Insulin Secreting Cells$577,633

R01 · FY2018 · DK · contact PI

Engineered Glucose Metabolism in Insulin Secreting Cells$577,633

R01 · FY2017 · DK · contact PI

A Biochemical Roadmap of Exercise Signaling - Pilot Project for MoTrPAC Consortium$116,893

U24 · FY2017 · DK

A Biochemical Roadmap of Exercise Signaling$112,250

U24 · FY2017 · DK

Development of Novel Therapies for NIDDM$1,966,913

P01 · FY2016 · DK · contact PI

Mechanism of Dysregulated Branched-chain Amino Acid Metabolism and Role in devel$1,347,489

P01 · FY2016 · DK · contact PI

Engineered Glucose Metabolism in Insulin Secreting Cells$577,633

R01 · FY2016 · DK · contact PI

Administrative Core$30,032

P01 · FY2016 · DK · contact PI

Development of Novel Therapies for NIDDM$1,966,913

P01 · FY2015 · DK · contact PI

Mechanism of Dysregulated Branched-chain Amino Acid Metabolism and Role in devel$1,347,489

P01 · FY2015 · DK · contact PI

Administrative Core$30,032

P01 · FY2015 · DK · contact PI

FASEB SRC on Glucose transport:Gateway to Metabolic Systems Biology$15,000

R13 · FY2015 · DK · contact PI

Development of Novel Therapies for NIDDM$1,966,913

P01 · FY2014 · DK · contact PI

Mechanism of Dysregulated Branched-chain Amino Acid Metabolism and Role in devel$1,347,489

P01 · FY2014 · DK · contact PI

Engineered Glucose Metabolism in Insulin Secreting Cells$512,435

R01 · FY2014 · DK · contact PI

Administrative Core$30,032

P01 · FY2014 · DK · contact PI

Development of Novel Therapies for NIDDM$1,898,072

P01 · FY2013 · DK · contact PI

Mechanism of Dysregulated Branched-chain Amino Acid Metabolism and Role in devel$1,300,327

P01 · FY2013 · DK · contact PI

Engineered Glucose Metabolism in Insulin Secreting Cells$494,500

R01 · FY2013 · DK · contact PI

Administrative Core$28,981

P01 · FY2013 · DK · contact PI

Development of Novel Therapies for NIDDM$2,008,384

P01 · FY2012 · DK · contact PI

Mechanism of Dysregulated Branched-chain Amino Acid Metabolism and Role in devel$1,388,960

P01 · FY2012 · DK · contact PI

Engineered Glucose Metabolism in Insulin Secreting Cells$512,435

R01 · FY2012 · DK · contact PI

Administrative Core$30,032

P01 · FY2012 · DK · contact PI

Engineered Glucose Metabolism in Insulin Secreting Cells$569,461

R01 · FY2011 · DK · contact PI

The Collaborative Cross Project on Obesity and Diabetes$517,189

R24 · FY2011 · DK

MITOCHONDRIAL FUNCTION AND INSULIN RESISTANCE$16,082

P41 · FY2011 · RR · contact PI

Development of Novel Therapies for NIDDM$1,914,412

P01 · FY2010 · DK · contact PI

Engineered Glucose Metabolism in Insulin Secreting Cells$472,189

R37 · FY2010 · DK · contact PI

Nkx6.1 REGULATION OF ISLET BIOLOGY$461,321

P01 · FY2010 · DK · contact PI

Nkx6.1 Regulation of Islet Biology$82,770

P01 · FY2010 · DK · contact PI

Engineered Glucose Metabolism in Insulin Secreting Cells$36,809

R37 · FY2010 · DK · contact PI

Development of Novel Therapies for NIDDM$28,960

P01 · FY2010 · DK · contact PI

BETA CELL METABOLISM$10,458

P41 · FY2010 · RR · contact PI

Development of Novel Therapies for NIDDM$1,883,574

P01 · FY2009 · DK · contact PI

Engineered Glucose Metabolism in Insulin Secreting Cells$465,477

R37 · FY2009 · DK · contact PI

Nkx6.1 REGULATION OF ISLET BIOLOGY$256,186

P01 · FY2009 · DK · contact PI

Nkx6.1 Regulation of Islet Biology$236,244

P01 · FY2009 · DK · contact PI

BETA CELL METABOLISM$17,838

P41 · FY2009 · RR · contact PI

Development of Novel Therapies for NIDDM$1,834,451

P01 · FY2008 · DK · contact PI

Engineered Glucose Metabolism in Insulin Secreting Cells$454,331

R37 · FY2008 · DK · contact PI

Nkx6.1 REGULATION OF ISLET BIOLOGY$245,951

P01 · FY2008 · DK · contact PI

Nkx6.1 Regulation of Islet Biology$232,746

P01 · FY2008 · DK · contact PI

INTERMEDIARY METABOLISM IN THE BETA CELL AND NOVEL THERAPIES FOR NIDDM$10,458

P41 · FY2008 · RR · contact PI

Development of Novel Therapies for NIDDM$1,861,338

P01 · FY2007 · DK · contact PI

Project 1: Nkx6.1 REGULATION OF ISLET BIOLOGY$519,013

P01 · FY2007 · DK · contact PI

Engineered Glucose Metabolism in Insulin Secreting Cells$452,319

R37 · FY2007 · DK · contact PI

Core--Administrative$92,062

P01 · FY2007 · DK · contact PI

INTERMEDIARY METABOLISM IN THE BETA CELL AND NOVEL THERAPIES FOR NIDDM$15,122

P41 · FY2007 · RR · contact PI

Development of Novel Therapies for NIDDM$1,880,230

P01 · FY2006 · DK · contact PI

Nkx6.1 REGULATION OF ISLET BIOLOGY$518,296

P01 · FY2006 · DK · contact PI

Engineered Glucose Metabolism in Insulin Secreting Cells$476,728

R37 · FY2006 · DK · contact PI

ADMINISTRATIVE CORE$91,990

P01 · FY2006 · DK · contact PI

ENGINEERED GLUCOSE METABOLISM IN INSULIN SECRETING CELLS$11,742

P41 · FY2006 · RR · contact PI

DEVELOPMENT OF NOVEL THERAPIES FOR NIDDM$11,740

P41 · FY2006 · RR · contact PI

Engineered Glucose Metabolism in Insulin Secreting Cells$406,919

R37 · FY2005 · DK

Engineering of Immunoprotection in beta-Cell Lines$259,877

R01 · FY2005 · DK

ENGINEERED GLUCOSE METABOLISM IN INSULIN SECRETING CELLS$20,951

P41 · FY2005 · RR

DEVELOPMENT OF NOVEL THERAPIES FOR NIDDM$20,951

P41 · FY2005 · RR

Engineered Glucose Metabolism in Insulin Secreting Cells$395,069

R37 · FY2004 · DK

Engineering of Immunoprotection in beta-Cell Lines$259,877

R01 · FY2004 · DK

DEVELOPMENT OF NOVEL THERAPIES FOR NIDDM$19,241

P41 · FY2004 · RR

ENGINEERED GLUCOSE METABOLISM IN INSULIN SECRETING CELLS$19,241

P41 · FY2004 · RR

Engineered Glucose Metabolism in Insulin Secreting Cells$383,560

R37 · FY2003 · DK

Engineering of Immunoprotection in beta-Cell Lines$259,877

R01 · FY2003 · DK

Engineered Glucose Metabolism in Insulin Secreting Cells$372,387

R01 · FY2002 · DK

Engineering of Immunoprotection in beta-Cell Lines$293,556

R01 · FY2002 · DK

GENE THERAPEUTIC STRATEGIES FOR CORRECTING GLUCOSE HOMEOSTATSIS$68,666

P41 · FY2002 · RR

METABOLIC GENE THERAPY OF DIABETES$0

P01 · FY2002 · DK

DEVELOPMENT OF NOVEL THERAPIES FOR NIDDM$1,421,967

P01 · FY2001 · DK

Engineered Glucose Metabolism in Insulin Secreting Cells$366,235

R01 · FY2001 · DK

METABOLIC GENE THERAPY OF DIABETES$0

P01 · FY2001 · DK

DEVELOPMENT OF NOVEL THERAPIES FOR NIDDM$1,426,644

P01 · FY2000 · DK

ENGINEERING OF IMMUNOPROTECTION IN BETA CELL LINES$287,383

R01 · FY2000 · DK

ENGINEERED GLUCOSE METABOLISM IN INSULIN SECRETING CELLS$160,112

R01 · FY2000 · DK

GENE THERAPEUTIC STRATEGIES FOR CORRECTING GLUCOSE HOMEOSTATSIS$13,906

P41 · FY2000 · RR

METABOLIC GENE THERAPY OF DIABETES$0

P01 · FY2000 · DK